Dulac Edward J III bought NTLA
March 1, 2026 · Form 4 insider transaction
Dulac Edward J III bought 87,543 shares of Intellia Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
87,543
Price
$0.00
Total value
N/A
InsiderDulac Edward J III
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 1, 2026
Filing dateMarch 3, 2026
Shares owned after87,543
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.